EMA gets keys to new HQ

18 November 2019
ema_building-credit_rob_acket

The European Medicines Agency (EMA) is now in possession of the keys to its new permanent headquarters in Amsterdam, Netherlands.

Since moving out of its London home in March 2019, the agency has been temporarily residing from another site in the Dutch city while the finishing touches were put to the tailor-made building.

Technical installation will now be installed, followed by IT configuration and testing, prior to staff moving in from January 13, 2020, with various health committee face-to-face meetings not taking place until full occupancy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical